Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Early Variations in Immune Aging

Authors not listed

Radboud University Medical Center · 2024

Abstract

Background: Despite an increase in lifespan over the last decades, our healthspan(definition) lags behind. In our aging population, it is pressing that we prevent age-related morbidities and associated burden on the health care system. Instead of investigating aging in already aged populations, the currently proposed study aims to elucidate the process of immune aging in relation to biological aging, demographic and lifestyle factors in young and midlife adults, and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes. Study design: A single-center, observational prospective cohort study in the Netherlands. Participants from priorly established cohorts will be invited to join the EVIA-study. We will obtain demographic and basic clinical data and biological samples (blood and stool) at baseline and after three years, with a short, yearly online questionnaire in between.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-05-31 MST

Cite this

APA
Anonymous. (2024). Early Variations in Immune Aging. <em>Radboud University Medical Center</em>. https://clinicaltrials.gov/study/NCT06295354
Vancouver
Anonymous. Early Variations in Immune Aging. Radboud University Medical Center. 2024.
BibTeX
@misc{anon2024EarlyV, title = {Early Variations in Immune Aging}, author = {Anonymous}, journal = {Radboud University Medical Center}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings